Report copyright - Trinity Delta · 2019. 3. 15. · MPH-966 for the treatment of alpha-1 antitrypsin deficiency (AATD). The strategy is to in-license more late-stage assets for the treatment of rare
Please pass captcha verification before submit form
Please pass captcha verification before submit form